---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-033491"
form_type: "8-K"
ticker: "CYRX"
cik: "0001124524"
company_name: "Cryoport, Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T22:47:57.519392+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cryoport FY 2023 revenue $233.3M (-2% YoY); net loss $99.6M; guides FY 2024 $242-252M

## Summary
- Q4 revenue $57.3M (-5% YoY); FY revenue $233.3M (-2% YoY). Services grew 8% but product fell 14%.
- Net loss for FY $99.6M includes $49.6M goodwill impairment; adjusted EBITDA negative $8.3M vs positive $13.9M prior year.
- Commercial Cell & Gene therapy revenue up 33% YoY; BioStorage/BioServices up 45%; record 675 clinical trials supported.
- FY 2024 revenue guidance $242-252M; expects progressive growth.
- Cash, equivalents & short-term investments $456.8M; $36M remaining under $100M repurchase program.

## SEC filing metadata
- accession: 0001104659-24-033491
- form_type: 8-K
- ticker: CYRX
- cik: 0001124524
- company_name: Cryoport, Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124524/000110465924033491/0001104659-24-033491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124524/000110465924033491/tm248611d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-033491
- JSON: https://secwatch.observer/filing/0001104659-24-033491.json
- Plain text: https://secwatch.observer/filing/0001104659-24-033491.txt

## Key facts
- Earnings Releases
  Cryoport, Inc. reported the fiscal year ended December 31, 2023 results: revenue $233.3 million.
  - Period: the fiscal year ended December 31, 2023
  - Revenue: $233.3 million
  - Result: reported results
  source text: Today we reported full year results including total revenue of $233.3 million for the fiscal year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124524/000110465924033491/0001104659-24-033491-index.htm
- Earnings Releases
  Cryoport, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $57.3 million.
  - Period: the fourth quarter ended December 31, 2023
  - Revenue: $57.3 million
  - Result: reported results
  source text: Total revenue for Q4 2023 was $57.3 million compared to $60.4 million for Q4 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124524/000110465924033491/0001104659-24-033491-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.